Labiotech.eu

Inside Labiotech 28 Mar 2023

Noticed something different? Labiotech is getting a new look for 2023!

Hi there, dear readers! I know, it’s been a while since we posted “behind the scene” updates from Labiotech so I’m sure you’re curious to know what we’ve been cooking during the past few months. Well, the reason is simple, we’ve been working hard on a whole new design for the website! With this new […]

March 28, 2023 - 3 minutesmins - By Joachim Eeckhout

CTDMO, biomanufacturing, Merck, infographic

Infographics by 28 Mar 2023

Infographic: Why choosing a client-centric CTDMO is critical when outsourcing biomanufacturing projects

In 2021, 28% of FDA approvals were granted to biologic drugs, showcasing the increasing demand for the biopharma industry to develop, manufacture and market biologic-based therapies. Biologic drugs include monoclonal antibodies and large molecules produced in mammalian cells, bringing the already complex process of drug development to a new level. Although the biomanufacturing of many […]

March 28, 2023 - 2 minutesmins - By Maya Chergova

News and Trends 24 Mar 2023

Beyond Biotech podcast 39: World Tuberculosis Day

March 24 is World Tuberculosis Day. To mark the occasion, we have conversations with Christopher Fox, senior vice president, formulations, at the Access to Advanced Health Institute; TB Alliance CEO Mel Spigelman; and Jane Theaker, CEO of PBD Biotech. This episode of the podcast is sponsored by Samplix. World Tuberculosis Day Tuberculosis is a leading […]

March 24, 2023

News and Trends 24 Mar 2023

Evotec receives $6.6M for tuberculosis drug discovery

On World Tuberculosis Day, Evotec SE has announced that it has received a $ 6.6 million grant from The Bill & Melinda Gates Foundation for drug discovery to tackle tuberculosis. The grant is the second award from the foundation to Evotec supporting TB drug discovery, and allows the company to progress a portfolio of TB […]

March 24, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 24 Mar 2023

Metabolism of RNA linked to leukemia

Researchers at Lund University Faculty of Medicine in Sweden have determined a novel mechanism linking the metabolism of ribonucleic acids, RNA, to the development of leukemia in myelodysplastic syndrome patients, MDS. In a study published in the Molecular Cell journal, they explain what makes hematopoietic stem cells acquire malignant traits in cancer. RNA splicing is […]

March 24, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 24 Mar 2023

Microbiome therapeutics biotech mbiomics raises €13M

mbiomics GmbH, a German microbiome biotech company developing the first generation of effective microbiome-based therapeutics has closed €13 million ($ 15 million) of a series A financing round led by MIG Capital. High-Tech Gründerfonds and Bayern Kapital joined the funding round together with a pool of private seed investors. mbiomics uses its proprietary, tailored high-resolution […]

March 24, 2023 - 2 minutesmins - By Jim Cornall

Opinion 24 Mar 2023

PAN-TB regimens to address growing TB drug resistance

By Dr. Charles Wells, head of therapeutics development at Gates Medical Research Institute As nearly one-quarter of the world’s population is presumed to be infected with Mycobacterium tuberculosis bacteria and are at risk for developing active tuberculosis (TB), the disease represents a major public health challenge globally. As reported by the World Health Organization (WHO), […]

March 24, 2023 - 5 minutesmins - By External Contributor

News and Trends 23 Mar 2023

OncoC4 and BioNTech partner in the commercialization of cancer drug candidate

German biopharma BioNTech has closed a licensing deal with the U.S.-based clinical-stage company OncoC4 for the development and commercialization of the latter’s lead candidate ONC-392, for the treatment of cancer. OncoC4 will receive $200 million upfront, and the transaction is expected to be completed in the first half of 2023. The company will also be […]

March 23, 2023 - 2 minutesmins - By Roohi Mariam Peter

News and Trends 23 Mar 2023

Gut microbiota to be harnessed as a tool to diagnose diseases

A recent study at the University of Jyväskylä in Finland compared the gut microbiota and gut-derived metabolites between healthy controls and individuals with fatty liver. The results revealed that certain microbial metabolites are associated with liver fat content. The fact that the gut microbiota associates with many diseases has raised the hope that they could […]

March 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 23 Mar 2023

Intracellular “smoke detector” discovery has skin disease therapy implications

A study by the University of Bonn in Germany could lead to therapies against skin and intestinal diseases in the medium term.Researchers at the universities of Bonn and Singapore have discovered a new intracellular “smoke detector.” The sensor warns of damage to the mitochondria – the microscopic power plants that supply the cell with energy. […]

March 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 23 Mar 2023

LIfT BioSciences hails breakthrough data for treating solid tumors

LIfT BioSciences has announced what it says are exciting preclinical data demonstrating that its immunomodulatory alpha neutrophil product (IMANp) possesses both cytotoxic and immunomodulatory functionalities. The company said these are commonly cited by medical professionals as being critical for potentially curing solid tumors in patients. LIfT BioSciences said this involved learning from the experience of other […]

March 23, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 23 Mar 2023

Flare Therapeutics sees $123M oncology boost

Flare Therapeutics Inc., a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, has announced a $123 million Series B financing. The financing was co-led by GordonMD Global Investments LP and Pfizer Ventures, with participation from existing investors Boxer Capital, Casdin Capital, Eventide Asset Management, Invus Financial Advisors, Nextech Invest […]

March 23, 2023 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Noticed something different? Labiotech is getting a new look for 2023!

Infographic: Why choosing a client-centric CTDMO is critical when outsourcing biomanufacturing projects

Beyond Biotech podcast 39: World Tuberculosis Day

Evotec receives $6.6M for tuberculosis drug discovery

Metabolism of RNA linked to leukemia

Microbiome therapeutics biotech mbiomics raises €13M

PAN-TB regimens to address growing TB drug resistance

OncoC4 and BioNTech partner in the commercialization of cancer drug candidate

Gut microbiota to be harnessed as a tool to diagnose diseases

Intracellular “smoke detector” discovery has skin disease therapy implications

LIfT BioSciences hails breakthrough data for treating solid tumors

Flare Therapeutics sees $123M oncology boost

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!